Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Fresenius Medical Care AG & Co.Kgaa (FME) NPV

Sell:€60.04 Buy:€60.08 Change: €0.70 (1.18%)
Xetra DAX:0.47%
Market closed |  Prices as at close on 3 April 2020 | Switch to live prices |
Sell:€60.04
Buy:€60.08
Change: €0.70 (1.18%)
Market closed |  Prices as at close on 3 April 2020 | Switch to live prices |
Sell:€60.04
Buy:€60.08
Change: €0.70 (1.18%)
Market closed |  Prices as at close on 3 April 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Contact details

Address:
Else-Kroener-Strasse 1
BAD HOMBURG VOR DER HOEHE
61352
Germany
Telephone:
+49 (6172) 6090
Website:
https://www.freseniusmedicalcare.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
FME
ISIN:
DE0005785802
Market cap:
€18.09 billion
Shares in issue:
298.34 million
Sector:
Health Care Services
Exchange:
Xetra
Country:
Germany
Currency:
Euro
Indices:
Xetra DAX

Key personnel

  • Dieter Schenk
    Chairman of the Supervisory Board
  • Rice Powell
    Chairman of the Management Board, Chief Executive Officer
  • Rolf Classon
    Independent Vice Chairman of the Supervisory Board
  • Helen Giza
    Chief Financial Officer, Member of the Management Board
  • Olaf Schermeier
    Member of the Management Board, Chief Executive Officer for Research and Development
  • Harry de Wit
    Member of the Management Board, Chief Executive Officer for Asia-Pacific
  • Frank Maddux
    Member of the Management Board
  • Katarzyna Mazur-Hofsaess
    Member of the Management Board, Chief Executive Officer for Europe, Middle East and Africa (EMEA)
  • William Valle
    Member of the Management Board, Chief Executive Officer for North America
  • Kent Wanzek
    Member of the Management Board, Chief Executive Officer for Global Manufacturing and Quality

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.